US 12,403,179 B2
Release of growth factors at wound healing stages
Joshua Sakon, Fayetteville, AR (US); Robert Beitle, Fayetteville, AR (US); Hazim Aljewari, Fayetteville, AR (US); Osamu Matsushita, Okayama (JP); and Stephanie Beitle, Fayetteville, AR (US)
Assigned to THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, Little Rock, AR (US); and NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY, Okayama (JP)
Filed by THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, Little Rock, AR (US); and NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY, Okayama (JP)
Filed on Feb. 18, 2022, as Appl. No. 17/675,762.
Claims priority of provisional application 63/151,023, filed on Feb. 18, 2021.
Prior Publication US 2022/0257715 A1, Aug. 18, 2022
Int. Cl. A61K 38/00 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61L 31/10 (2006.01); A61L 31/16 (2006.01)
CPC A61K 38/1825 (2013.01) [A61K 38/164 (2013.01); A61K 38/1709 (2013.01); A61L 31/10 (2013.01); A61L 31/16 (2013.01)] 6 Claims
 
1. A collagen-binding agent comprising SEQ ID NO:1.